ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,278Medicare Part D Prescriptions Filled, Including Refills

Rank: 99 out of 930

$614K Total Retail Price of All Prescriptions

Rank: 73 out of 930

421 Patients Receiving at Least One Drug in Part D
48% Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Washington
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Washington
LISINOPRIL 412 175 100 1 1
METFORMIN HCL 388 187 86 2 9
AMLODIPINE BESYLATE 384 209 92 3 5
TRAMADOL HCL 323 95 60 4 26
LEVOTHYROXINE SODIUM 312 129 52 5 2
HYDROCHLOROTHIAZIDE 247 129 54 6 10
OMEPRAZOLE 244 119 39 7 4
SIMVASTATIN 239 131 49 8 3
FENOFIBRATE* 225 60 40 9 76
GABAPENTIN 201 69 33 10 14
ATORVASTATIN CALCIUM 193 88 39 11 6
GLIPIZIDE 192 103 41 12 43
PROAIR HFA 176 61 44 13 35
TRAZODONE HCL 173 83 31 14 22
WARFARIN SODIUM 173 83 24 14 12
FUROSEMIDE 157 66 30 16 8
METOPROLOL TARTRATE 155 89 38 17 13
LOVASTATIN 153 71 45 18 19
RANITIDINE HCL 153 63 42 18 31
ATENOLOL 150 100 38 20 15
CRESTOR 148 49 32 21 37
AMITRIPTYLINE HCL 113 30 19 R 22 78
SPIRIVA 113 50 20 22 48
IBUPROFEN 112 48 24 24 91
LOSARTAN POTASSIUM 108 89 30 25 11
ADVAIR DISKUS 107 54 17 26 50
POTASSIUM CHLORIDE 107 61 28 26 16
FLUTICASONE PROPIONATE 105 52 34 28 24
BACLOFEN 104 <11 23 29 79
BUSPIRONE HCL 103 35 19 30 143
BUPROPION HCL SR 100 <11 21 31 95
CYCLOBENZAPRINE HCL 99 18 26 R 32 82
CITALOPRAM HBR 97 49 14 33 17
FLUOXETINE HCL 95 22 15 34 40
LANTUS 93 36 22 35 46
ZOLPIDEM TARTRATE 93 16 13 35 25
PAROXETINE HCL 91 40 17 37 61
NIASPAN 86 15 16 38 190
ALLOPURINOL 86 46 19 38 30
QVAR 84 40 22 40 180
METOPROLOL SUCCINATE 83 46 23 41 18
ALENDRONATE SODIUM 81 76* 21 42 29
PRAVASTATIN SODIUM 79 40 24 43 20
MIRTAZAPINE 75 <11 <11 44 42
SERTRALINE HCL 71 19 23 45 21
ENALAPRIL MALEATE 71 37 17 45 90
MONTELUKAST SODIUM 66 <11 <11 47 71
LANTUS SOLOSTAR 66 23 13 47 56
PROPRANOLOL HCL 65 11 12 49 122
TIZANIDINE HCL 62 33 16 50 137
VENLAFAXINE HCL ER 59 <11 <11 51 75
CLONAZEPAM 59 <11 <11 B 51 49
HYDROCODONE-ACETAMINOPHEN 54 <11 <11 S3 53 7
POLYETHYLENE GLYCOL 3350 53 34 15 54 62
CLOPIDOGREL 53 16 12 54 28
LEVEMIR FLEXPEN 53 <11 <11 54 165
CARVEDILOL 52 <11 <11 57 33
HYDROXYZINE HCL 51 <11 14 R 58 267
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 5, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.